According to a report by Reports and Data, the global Biosimulation Market size was USD 2.78 billion in 2022 and is projected to have a revenue CAGR of 16% over the forecast period. Biosimulation is becoming increasingly popular in drug development as it can be used to predict the safety and efficacy of a drug candidate, eliminating the need for clinical trials, thereby saving time and money....